CROI 2019: key news stories
Find out more about the headlines from the Conference on Retroviruses and Opportunistic Infections 2019 (CROI) in our round-up of conference news.
Browsing: HCV
Three new strains of hepatitis C discovered in Africa
The largest population study of hepatitis C in Africa has discovered three new strains of the virus with unknown susceptibility to currently used antiviral treatments.
IDWeek: Opioid-using youth could miss out on hepatitis C screening and treatment
During the current opioid crisis, only one-third of youths diagnosed with opioid use disorder were tested for hepatitis C, according to the results of a large national sample presented at IDWeek.
Hepatitis C-infected kidneys safe for transplantation
A study in 20 patients has demonstrated that transplantation followed by antiviral therapy has been successful in patients receiving kidneys from hepatitis C-infected donors.
Modeling in hepatitis – still a long way to go
Author, Khaled Barakat, argues that computational modeling has a great potential in directing hepatitis research, to understand the liver and to discover better and more effective treatments.
IDHTalks at ECCMID17: Researching hepatitis – an interview with William Irving
Reporting from ECCMID17, we spoke to William Irving about his current work on hepatitis C and his thoughts on the future of this field.
Genetic polymorphisms could help to determine outcomes in hepatitis C cirrhosis patients
Genotyping hepatitis C patients with advanced cirrhosis could help predict improvement after treatment, according to research presented at Digestive Disease Week®.
IDHTalks at ECCMID17: Managing hepatitis – an interview with Joop Arends
In this interview, Joop Arends discusses his thoughts on the future of diagnosis and management of hepatitis C, and also gives us his highlights from ECCMID.
Host–virus interactions in hepatitis – an interview with Marcus Dorner
In line with Hepatitis Awareness Month, we spoke to Marcus Dorner about his current research into the host–virus interactions in hepatitis B and C infection, their implications for vaccine development and more.
Could hepatitis infection increase the risk of Parkinson’s disease?
Researchers have demonstrated that both hepatitis B and hepatitis C infection are associated with an increased risk of Parkinson’s disease.
